Terms: = Cervical cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1
46 results:
1. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract] [Full Text] [Related]
2. A Cellular Senescence-Related Signature Predicts cervical cancer Patient Outcome and Immunotherapy Sensitivity.
Shao H; Li X; Wu P; Chen Z; Zhang C; Gu H
Reprod Sci; 2023 Dec; 30(12):3661-3676. PubMed ID: 37580647
[TBL] [Abstract] [Full Text] [Related]
3. Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and
Palafox-Mariscal LA; Ortiz-Lazareno PC; Jave-Suárez LF; Aguilar-Lemarroy A; Villaseñor-García MM; Cruz-Lozano JR; González-Martínez KL; Méndez-Clemente AS; Bravo-Cuellar A; Hernández-Flores G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445768
[TBL] [Abstract] [Full Text] [Related]
4. cancer-associated fibroblast-derived pai-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.
Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W
J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in cervical Carcinoma Cells.
Ruckriegl S; Loris J; Wert K; Bauerschmitz G; Gallwas J; Gründker C
Cancer Genomics Proteomics; 2023; 20(3):281-297. PubMed ID: 37093686
[TBL] [Abstract] [Full Text] [Related]
6. Photodynamic Therapy and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with AuNPs.
Zhang W; Lu Y; Zang Y; Han J; Xiong Q; Xiong J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163150
[TBL] [Abstract] [Full Text] [Related]
7. pai-1 Polymorphisms Have Significant Associations With cancer Risk, Especially Feminine cancer.
Wang J; Peng Y; Guo H; Li C
Technol Cancer Res Treat; 2021; 20():15330338211037813. PubMed ID: 34521295
[TBL] [Abstract] [Full Text] [Related]
8. Identification of an immune classification for cervical cancer and integrative analysis of multiomics data.
Lyu X; Li G; Qiao Q
J Transl Med; 2021 May; 19(1):200. PubMed ID: 33971902
[TBL] [Abstract] [Full Text] [Related]
9. In vivo Multi-scale Photoacoustic Imaging Guided Photothermal Therapy of cervical cancer based on Customized Laser System and Targeted Nanoparticles.
Qiu T; Lan Y; Wei Z; Zhang Y; Lin Y; Tu C; Mao G; Zhang L; Yang B; Zhang J
Int J Nanomedicine; 2021; 16():2879-2896. PubMed ID: 33883896
[TBL] [Abstract] [Full Text] [Related]
10. Pancancer survival analysis of cancer hallmark genes.
Nagy Á; Munkácsy G; Győrffy B
Sci Rep; 2021 Mar; 11(1):6047. PubMed ID: 33723286
[TBL] [Abstract] [Full Text] [Related]
11. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).
Ye Y; Peng L; Vattai A; Deuster E; Kuhn C; Dannecker C; Mahner S; Jeschke U; von Schönfeldt V; Heidegger HH
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2189-2203. PubMed ID: 32488496
[TBL] [Abstract] [Full Text] [Related]
12. One-Dimensional Fe
Liu Y; Zhen W; Wang Y; Liu J; Jin L; Zhang T; Zhang S; Zhao Y; Song S; Li C; Zhu J; Yang Y; Zhang H
Angew Chem Int Ed Engl; 2019 Feb; 58(8):2407-2412. PubMed ID: 30600877
[TBL] [Abstract] [Full Text] [Related]
13. Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.
Jouanneau M; McClary B; Reyes JC; Chen R; Chen Y; Plunkett W; Cheng X; Milinichik AZ; Albone EF; Liu JO; Romo D
Bioorg Med Chem Lett; 2016 Apr; 26(8):2092-7. PubMed ID: 26951751
[TBL] [Abstract] [Full Text] [Related]
14. Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Kojima S; Yamashita A; Tomio K; Nagamatsu T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
Int J Oncol; 2016 Feb; 48(2):829-35. PubMed ID: 26676222
[TBL] [Abstract] [Full Text] [Related]
15. serpine1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.
Dhanda J; Triantafyllou A; Liloglou T; Kalirai H; Lloyd B; Hanlon R; Shaw RJ; Sibson DR; Risk JM
Br J Cancer; 2014 Nov; 111(11):2114-21. PubMed ID: 25268377
[TBL] [Abstract] [Full Text] [Related]
16. Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.
Zhang G; Miyake M; Lawton A; Goodison S; Rosser CJ
BMC Cancer; 2014 May; 14():310. PubMed ID: 24885595
[TBL] [Abstract] [Full Text] [Related]
17. pai-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation.
Giacoia EG; Miyake M; Lawton A; Goodison S; Rosser CJ
Mol Cancer Res; 2014 Mar; 12(3):322-34. PubMed ID: 24464915
[TBL] [Abstract] [Full Text] [Related]
18. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.
Gomes-Giacoia E; Miyake M; Goodison S; Rosser CJ
Mol Cancer Ther; 2013 Dec; 12(12):2697-708. PubMed ID: 24072883
[TBL] [Abstract] [Full Text] [Related]
19. Polymorphisms in the genes related to angiogenesis are associated with uterine cervical cancer.
Ramos-Flores C; Romero-Gutiérrez T; Delgado-Enciso I; Maldonado GE; Plascencia VM; Vazquez-Vuelvas OF; Quintero-Ramos A; Mejía RC; Espinoza-Gomez F; Baltazar-Rodriguez LM; Valdez-Velazquez LL
Int J Gynecol Cancer; 2013 Sep; 23(7):1198-204. PubMed ID: 23873179
[TBL] [Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor-1 (pai-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors.
Lara PC; Lloret M; Valenciano A; Clavo B; Pinar B; Rey A; Henríquez-Hernández LA
Strahlenther Onkol; 2012 Dec; 188(12):1139-45. PubMed ID: 23111469
[TBL] [Abstract] [Full Text] [Related]
[Next]
